Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy.

Goldmann T, Drömann D, Radtke J, Marwitz S, Lang DS, Schultz H, Vollmer E.

Virchows Arch. 2008 Mar;452(3):347-8. doi: 10.1007/s00428-008-0579-8. No abstract available.

PMID:
18214534
[PubMed - indexed for MEDLINE]
2.

Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

Xie Y, Minna JD.

J Clin Oncol. 2010 Oct 10;28(29):4404-7. doi: 10.1200/JCO.2010.31.0144. Epub 2010 Sep 7. No abstract available.

PMID:
20823415
[PubMed - indexed for MEDLINE]
Free Article
3.

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines.

Shimizu J, Horio Y, Osada H, Hida T, Hasegawa Y, Shimokata K, Takahashi T, Sekido Y, Yatabe Y.

Respirology. 2008 Jun;13(4):510-7. doi: 10.1111/j.1440-1843.2008.01302.x.

PMID:
18494946
[PubMed - indexed for MEDLINE]
4.

Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer.

Oguri T, Isobe T, Suzuki T, Nishio K, Fujiwara Y, Katoh O, Yamakido M.

Int J Cancer. 2000 Apr 1;86(1):95-100.

PMID:
10728601
[PubMed - indexed for MEDLINE]
5.

Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.

Denlinger CE, Rundall BK, Keller MD, Jones DR.

Ann Thorac Surg. 2004 Oct;78(4):1207-14; discussion 1207-14.

PMID:
15464472
[PubMed - indexed for MEDLINE]
6.

Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.

Rosell R, Felip E, Taron M, Majo J, Mendez P, Sanchez-Ronco M, Queralt C, Sanchez JJ, Maestre J.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4215s-4219s.

PMID:
15217961
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression of lung-resistance protein gene is not associated with platinum drug exposure in lung cancer.

Oguri T, Fujiwara Y, Ochiai M, Fujitaka K, Miyazaki M, Takahashi T, Yokozaki M, Isobe T, Ohune T, Tsuya T, Katoh O, Yamakido M.

Anticancer Res. 1998 Nov-Dec;18(6A):4159-62.

PMID:
9891461
[PubMed - indexed for MEDLINE]
8.

Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.

Ikeda R, Vermeulen LC, Lau E, Jiang Z, Sachidanandam K, Yamada K, Kolesar JM.

Int J Oncol. 2011 Feb;38(2):513-9. doi: 10.3892/ijo.2010.866. Epub 2010 Dec 7.

PMID:
21152861
[PubMed - indexed for MEDLINE]
9.

The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.

Nishi M, Abe Y, Fujimori S, Hamamoto A, Inoue Y, Miyazaki N, Oida Y, Ikoma N, Ohnishi Y, Yamazaki H, Ueyama Y, Nakamura M.

Oncol Rep. 2005 Aug;14(2):421-4.

PMID:
16012725
[PubMed - indexed for MEDLINE]
10.

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

Rosell R, Scagliotti G, Danenberg KD, Lord RV, Bepler G, Novello S, Cooc J, Crinò L, Sánchez JJ, Taron M, Boni C, De Marinis F, Tonato M, Marangolo M, Gozzelino F, Di Costanzo F, Rinaldi M, Salonga D, Stephens C.

Oncogene. 2003 Jun 5;22(23):3548-53.

PMID:
12789263
[PubMed - indexed for MEDLINE]
11.

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, Sharma A, Simon G.

J Clin Oncol. 2006 Oct 10;24(29):4731-7. Epub 2006 Sep 11.

PMID:
16966686
[PubMed - indexed for MEDLINE]
Free Article
12.

Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.

Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, Wada H, Date H, Miyahara R.

Cancer. 2009 Jun 1;115(11):2580-93. doi: 10.1002/cncr.24281.

PMID:
19309748
[PubMed - indexed for MEDLINE]
Free Article
13.

Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.

Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RD, Breuer RH, Egging M, van Wijk IJ, Oudejans CB.

Clin Cancer Res. 2002 Apr;8(4):1082-6.

PMID:
11948117
[PubMed - indexed for MEDLINE]
Free Article
14.

Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.

Dagnon K, Pacary E, Commo F, Antoine M, Bernaudin M, Bernaudin JF, Callard P.

Clin Cancer Res. 2005 Feb 1;11(3):993-9.

PMID:
15709164
[PubMed - indexed for MEDLINE]
Free Article
15.

RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.

Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, Wang Y, Shentu JZ.

Cancer Chemother Pharmacol. 2012 May;69(5):1277-87. doi: 10.1007/s00280-012-1834-x.

PMID:
22302408
[PubMed - indexed for MEDLINE]
16.

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.

de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique.

Clin Cancer Res. 2012 May 15;18(10):2976-86. doi: 10.1158/1078-0432.CCR-11-2797. Epub 2012 Mar 20.

PMID:
22434665
[PubMed - indexed for MEDLINE]
Free Article
17.

Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy.

Tassinari D, Fochessati F, Arcangeli V, Panzini I, Ravaioli A, Sartori S.

Lung Cancer. 2003 Jan;39(1):107-8. No abstract available.

PMID:
12499103
[PubMed - indexed for MEDLINE]
18.

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.

Bonanno L, Costa C, Majem M, Favaretto A, Rugge M, Rosell R.

Ann Oncol. 2013 Apr;24(4):1130-2. doi: 10.1093/annonc/mdt063. Epub 2013 Feb 20. No abstract available.

PMID:
23429864
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.

Ceppi P, Papotti M, Monica V, Lo Iacono M, Saviozzi S, Pautasso M, Novello S, Mussino S, Bracco E, Volante M, Scagliotti GV.

Mol Cancer Ther. 2009 Nov;8(11):3066-74. doi: 10.1158/1535-7163.MCT-09-0151. Epub 2009 Oct 27.

PMID:
19861409
[PubMed - indexed for MEDLINE]
Free Article
20.

Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.

Zhong S, Fields CR, Su N, Pan YX, Robertson KD.

Oncogene. 2007 Apr 19;26(18):2621-34. Epub 2006 Oct 9.

PMID:
17043644
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk